4.6 Article

Complement Activation by Ceramide Transporter Proteins

期刊

JOURNAL OF IMMUNOLOGY
卷 192, 期 3, 页码 1154-1161

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1301673

关键词

-

资金

  1. European Commission Sixth Framework Program [EC-FP6]
  2. EC-FP6 grant (European NanoBioPharmaceutics research initiative)
  3. Prinses Beatrix Fonds [MAR03-0115]
  4. Francaise contre les Myopathies
  5. Genmab
  6. Netherlands Organization for Scientific Research
  7. Brain Foundation of The Netherlands

向作者/读者索取更多资源

C1q is the initiator of the classical complement pathway and, as such, is essential for efficient opsonization and clearance of pathogens, altered self-structures, and apoptotic cells. The ceramide transporter protein (CERT) and its longer splicing isoform CERTL are known to interact with extracellular matrix components, such as type IV collagen, and with the innate immune protein serum amyloid P. In this article, we report a novel function of CERT in the innate immune response. Both CERT isoforms, when immobilized, were found to bind the globular head region of C1q and to initiate the classical complement pathway, leading to activation of C4 and C3, as well as generation of the membrane attack complex C5b-9. In addition, C1q was shown to bind to endogenous CERTL on the surface of apoptotic cells. These results demonstrate the role of CERTs in innate immunity, especially in the clearance of apoptotic cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据